Stock Rating Upgrade
In recent days the Value Trend Rating for Adverum Biotechnologies Inc (NASDAQ: ADVM) improved from D to C reflecting improving fundamentals and high Appreciation Potential.
Recent Price Action
On 8/1/24, Adverum Biotechnologies Inc (NASDAQ: ADVM) stock enjoyed a large increase of 2.0%, closing at $7.57. However, trading volume in this advance was below average at 70% of normal. The stock has been weak relative to the market over the last nine months and has declined -3.8% during the last week.
Current PriceTarget Research Rating
ADVM is expected to continue to be a modest Value Eraser reflecting capital returns that are forecasted to fall short of the cost of capital.
Adverum Biotechnologies has a current Value Trend Rating of C (Low Neutral). This VT Rating improved in recent days from D previously. The Value Trend Rating reflects consistent signals from PTR’s two proprietary measures of a stock’s attractiveness. Adverum Biotechnologies has a neutral Appreciation Score of 55 and a slightly negative Power Rating of 31, producing the Low Neutral Value Trend Rating.
Be the first to comment